Delivery Order SPE2DB22D3102-SPE2DB25FL2SX
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a $10,386.66 firm fixed price delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml). This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order is scheduled for completion by July 31, 2025, with performance to be executed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order from the Defense Logistics Agency valued at $5,377.59 for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. The contract is a firm fixed price delivery order awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. This award was not designated as a set-aside contract and represents a small-value transaction typical of the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $10,069.95 for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml). The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, carries a firm fixed price structure and was not designated as a set-aside award. Performance will be executed at AmerisourceBergen's corporate office location...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,870.86 and is scheduled for completion by July 31, 2025. The award represents a child contract action under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 20, 2025, valued at $9,486.77. The contract calls for the delivery of Ozempic 0.25–0.5 mg/dose pens (3 mL) to support federal medical supply requirements. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for ultimate completion by August 21, 2025, with...
- The Defense Logistics Agency awarded a delivery order valued at $1,308.27 to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pen 3ml on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a contract ceiling value of $91,339.91. This is a firm fixed-price, non-competitive set-aside delivery order utilizing a competitive award process. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This delivery order falls...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 18, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. The contract is valued at $3,759.96 and carries a firm fixed price with an ultimate completion date of August 19, 2025. The award utilized competitive procurement procedures with no set-aside designation. The place of performance is identified as the vendor's corporate office in Conshohocken, Pennsylvania. This...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $2,989.78 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to supply OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all work to be completed by December 1, 2023. As a prime contractor supporting DLA Troop Support Medical programs, Amerisourcebergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 18, 2025, for Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $1,253.32. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under...